ITUS Corp (NASDAQ:ITUS)

3.36
Delayed Data
As of Feb 23
 +0.03 / +0.90%
Today’s Change
0.60
Today|||52-Week Range
6.43
+42.37%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$55.9M

Company Description

ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Contact Information

ITUS Corp.
3150 Almaden Expressway
San Jose California 95118
P:(408) 708-9808
Investor Relations:

Employees

Shareholders

Mutual fund holders4.99%
Individual stakeholders10.81%
Other institutional0.79%

Top Executives

Amit KumarExecutive Chairman, President & CEO
Michael J. CatelaniChief Operating & Financial Officer
John A. RoopSenior Vice President-Engineering
Anthony CampisiVice President-Engineering